Perth, July 18, 2016 AEST (ABN Newswire) – MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide its shareholders with the below Company update, in the form of a QA session with Managing Director Andreas Gedeon.
MMJ recently achieved a significant operational milestone with its flagship Duncan Facility granted a Marihuana for Medical Purposes Regulations (“MMPR”) production licence by Health Canada. This milestone is considered a key catalyst for the Company in its transition towards becoming a leading supplier of medical cannabis globally.
Managing Director QA Session July 2016:
1. Andreas, you
... read more at: http://www.abnnewswire.net/press/en/84191/